This feature article is a spec piece I created to explore long-form health journalism for a patient-focused audience. It looks at CGRP inhibitors, a relatively new option for migraine prevention, and introduces the topic in a way that feels approachable yet medically accurate, reflecting the editorial standards of high-quality health publications.

The text follows a structured narrative that walks readers through what CGRP is, how these medications work, and what benefits and side effects patients may expect. My goal was to make complex science feel understandable to people who live with migraine or care for someone who does, helping them feel more confident when discussing treatment options with their doctors.

The tone stays evidence-based and balanced while remaining empathetic and accessible. Clarity, trust, and usefulness were at the heart of the piece.